Comorbidity of bipolar and substance use disorders in national surveys of general populations, 1990-2015: Systematic review and meta-analysis.
paper
Cited
Public
Unavailable
- Authors
- Hunt, Glenn E; Malhi, Gin S; Cleary, Michelle; Lai, Harry Man Xiong; Sitharthan, Thiagarajan
- Year
- 2016
- Journal
- Journal of affective disorders
- PMID
- 27426694
- DOI
- 10.1016/j.jad.2016.06.051
BACKGROUND: Substance use disorders (SUDs) are common in people with a bipolar disorder (BD). This systematic review and meta-analysis aimed to estimate the prevalence rates of SUDs in persons with BD based on national or international surveys of household populations. METHODS: Studies published from 1990 to Dec 31, 2015 were identified from MEDLINE, EMBASE. psychINFO, and CINAHL databases and reference lists. We calculated prevalence rates and conducted meta-analysis with random-effects model. RESULTS: We identified 9 unique surveys of which two surveys were repeated 10 years later using independent samples. The total sample size was 218,397 subjects. The mean prevalence for any illicit drug use disorder was 17%, for alcohol use disorder (AUD) it was 24% and SUD it was 33%. The strongest associations were found between BD and illicit drug use (pooled odds ratio (OR) 4.96, 95% CI 3.98-6.17) followed closely by BD and AUD (OR 4.09, 95% CI 3.37-4.96). The association was higher for BD respondents using illicit drugs compared to bipolar II respondents (ORs 7.48 vs. 3.30). LIMITATIONS: Some of the meta-analysis grouped illicit substances together without taking into consideration types of substance use which may differ widely between countries and over time. All included studies were cross-sectional so onset and causality can not be determined. CONCLUSIONS: The meta-analysis revealed that people with an alcohol use disorder were 4.1 times of greater risk of having a BD compared to those without an AUD. The risks were even higher for illicit drug users where they were 5.0 times of greater risk of having BD compared to non-users. These data confirm strong associations between co-occurring SUDs and BD, indicating a need for more informative studies to help develop better interventions in treating persons with BD and comorbid SUDs.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | 2023 | 37626487 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Comorbidity Patterns in Alcohol Use Disorder: A Short-Term Residential Program Pilot Study. | Stavrou S et al. | — | 2026 | → |
| Transdiagnostic and Disorder-Level Genome-Wide Association Studies Enhance Precision of Substance Use and Psychiatric Genetic Risk Profiles in African and European Ancestries. | Khan Y et al. | — | 2026 | → |
| An examination of inpatient ward and secondary community care stay costs for individuals with complex mental health needs in the UK. | Saini P et al. | — | 2025 | → |
| Bipolar Disorder Hospitalizations and Substance Use Disorders: A Nationwide Retrospective Study From 2008 To 2015. | Valente L et al. | — | 2025 | → |
| Clinical and metabolic correlates of DSM-5 mixed features in subjects with bipolar depression and mania: A cross-sectional study. | Bartoli F et al. | — | 2025 | → |
| Determining the diagnostic cut-off on the Chinese version of severity of dependence scale for DSM-5 stimulant use disorder. | Chung AKK et al. | — | 2025 | → |
| Factors influencing perceived benefits and behavioral intention to use mental health chatbots among professional employees: an empirical study. | Naji GMA et al. | — | 2025 | → |
| Genomics of Bipolar Disorder: What the Clinician Needs to Know. | McQuillin A et al. | — | 2025 | → |
| Global Diversity in Bipolar Disorder: The Role of Cultural and Social Differences With a View to Genomics. | Fullerton JM et al. | — | 2025 | → |
| Neurobiological intersections of stress and substance use disorders. | Juliano VAL et al. | — | 2025 | → |
| Nurses' Perceptions of Patients With Co-Occurring Psychiatric and Substance Use Disorders in Psychiatric Settings: A Grounded Theory Study. | Bertrand E et al. | — | 2025 | → |
| Psychosocial interventions for people with comorbid substance use disorders in people with severe mental health conditions in low- and middle-income countries: scoping review. | Mihretu A et al. | — | 2025 | → |
| Specificity of environmental risk factors for schizophrenia, bipolar disorders, and depressive disorders - umbrella review. | Miettunen J et al. | — | 2025 | → |
| Association of early- and late-life bipolar disorder with incident dementia. A Danish cohort study. | Nielsen JL et al. | — | 2024 | → |
| Certified Community Behavioral Health Clinic Services for Clients With Co-occurring Disorders: A Latent Class Approach. | Hu Y et al. | — | 2024 | → |
| Dynamic time warp analysis of individual symptom trajectories in individuals with bipolar disorder. | Mesbah R et al. | — | 2024 | → |
| Prevalence of substance use among a sample of patients attending an outpatient psychiatric clinic in Amman, Jordan. | Abbasi LN et al. | — | 2024 | → |
| Psychological distress among postpartum women who took opioids during pregnancy: the role of perceived stigma in healthcare settings. | Bann CM et al. | — | 2024 | → |
| TAPS-tool reveals severe under detection of substance use problems in patients with severe mental illness. | Seelen-de Lang B et al. | — | 2024 | → |
| The prevalence and associated characteristics of Bipolar Disorder diagnosis among admitted patients at three tertiary psychiatric hospitals in Zimbabwe: A cross sectional study. | Mwamuka R et al. | — | 2024 | → |
| Workforce estimate to treat mental disorders in the Kingdom of Saudi Arabia. | Lee E et al. | — | 2024 | → |
| Antimanic Efficacy, Tolerability, and Acceptability of Clonazepam: A Systematic Review and Meta-Analysis. | Lappas AS et al. | — | 2023 | → |
| A Prospective Comparison of Bipolar I and II Subjects with and without Comorbid Cannabis Use Disorders from the COGA Dataset. | Preuss UW et al. | — | 2023 | → |
| A Qualitative Study of Emergency Physicians' and Nurses' Experiences Caring for Patients With Psychiatric Conditions and/or Substance Use Disorders. | Isbell LM et al. | — | 2023 | → |
| Characterizing the clinical profile of mania without major depressive episodes: a systematic review and meta-analysis of factors associated with unipolar mania. | Bartoli F et al. | — | 2023 | → |
| Comorbidities of Major Depressive Disorder and Bipolar Disorders in Patients with Substance Use Disorder in Iran Psychiatric Hospital: A Cross-sectional Study. | Oladikalarijani M et al. | — | 2023 | → |
| Risk for alcohol use problems in severe mental illness: Interactions with sex and racial/ethnic minority status. | Levit JD et al. | — | 2023 | → |
| Substance use outcomes among individuals with severe mental illnesses receiving assertive community treatment: A systematic review. | Abufarsakh B et al. | — | 2023 | → |
| The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence. | Keramatian K et al. | — | 2023 | → |
| The experience of mood disorder and substance use: An integrative review. | Crowe M et al. | — | 2023 | → |
| Trends in CV mortality among patients with known mental and behavioral disorders in the US between 1999 and 2020. | Ebert T et al. | — | 2023 | → |
| Triple Diagnosis of Attention-Deficit/Hyperactivity Disorder with Coexisting Bipolar and Alcohol Use Disorders: Clinical Aspects and Pharmacological Treatments. | Weiss F et al. | — | 2023 | → |
| Workforce Estimate to Treat Mental Disorders in the Kingdom of Saudi Arabia | Lee E et al. | — | 2023 | — |
| Age-related changes in physiology in individuals with bipolar disorder. | Mutz J et al. | — | 2022 | → |
| Alcohol and drug use among clients receiving internet-delivered cognitive behavior therapy for anxiety and depression in a routine care clinic - Demographics, use patterns, and prediction of treatment completion and outcomes. | Sundström C et al. | — | 2022 | → |
| Association between polarity of first episode and solar insolation in bipolar I disorder. | Bauer M et al. | — | 2022 | → |
| Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence. | Kuhns L et al. | — | 2022 | → |
| A systematic review of the perceptions and attitudes of mental health nurses towards alcohol and other drug use in mental health clients. | Merrick TT et al. | — | 2022 | → |
| Bipolar Disorder and Polysubstance Use Disorder: Sociodemographic and Clinical Correlates. | Aguglia A et al. | — | 2022 | → |
| Cocaine Use Disorder (CUD): Current Clinical Perspectives. | Schwartz EKC et al. | — | 2022 | → |
| Comorbidity between mood and substance-related disorders: A systematic review and meta-analysis. | Saha S et al. | — | 2022 | → |
| Comorbidity of adult ADHD and substance use disorder in a sample of inpatients bipolar disorder in Iran. | Badrfam R et al. | — | 2022 | → |
| Developing "MinDag" - an app to capture symptom variation and illness mechanisms in bipolar disorder. | Bjella TD et al. | — | 2022 | → |
| Gender-related associations between psychiatric disorders and alcohol use disorder: Findings from the french "Mental health in the general population" survey. | Lespine LF et al. | — | 2022 | → |
| Influence of childhood maltreatment on prevalence, onset, and persistence of psychiatric comorbidities and suicide attempts in bipolar disorders. | Grillault Laroche D et al. | — | 2022 | → |
| Preventive Medication Patterns in Bipolar Disorder and Their Relationship With Comorbid Substance Use Disorders in a Cross-National Observational Study. | Icick R et al. | — | 2022 | → |
| The prevalence and clinical correlates of medical disorders comorbidities in patients with bipolar disorder. | Wang Z et al. | — | 2022 | → |
| The relationships between use of alcohol, tobacco and coffee in adolescence and mood disorders in adulthood. | Bolstad I et al. | — | 2022 | → |
| Antisocial Personality Disorder in Bipolar Disorder: A Systematic Review. | Carbone EA et al. | — | 2021 | → |
| Bipolar Disorder and Comorbid Use of Illicit Substances. | Preuss UW et al. | — | 2021 | → |
| Cannabidiol Cigarettes as Adjunctive Treatment for Psychotic Disorders - A Randomized, Open-Label Pilot-Study. | Köck P et al. | — | 2021 | → |
| Comorbid Bipolar and Alcohol Use Disorder-A Therapeutic Challenge. | Grunze H et al. | — | 2021 | → |
| Developmental trajectories in psychiatric disorders: does substance/alcohol use moderate the effects of affective temperaments as moderators of age at onset? A study in post-acute, hospitalized patients with psychotic or DSM-5 bipolar or major depressive disorders. | Perrini F et al. | — | 2021 | → |
| Diagnosis of Opioid Use Disorder by Youths Assessed in Acute Care Settings in British Columbia, Canada. | Krebs E et al. | — | 2021 | → |
| Disentangling the Association between ADHD and Alcohol Use Disorder in Individuals Suffering from Bipolar Disorder: A Systematic Review and Meta-Analysis. | Bartoli F et al. | — | 2021 | → |
| Effects of psychotherapy on comorbid bipolar disorder and substance use disorder: A systematic review. | Crowe M et al. | — | 2021 | → |
| Efficacy and acceptability of pharmacotherapy for comorbid anxiety symptoms in bipolar disorder: A systematic review and meta-analysis. | Cullen C et al. | — | 2021 | → |
| [Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study]. | Vinnikova MA et al. | — | 2021 | → |
| Greenspace programmes for mental health: A survey study to test what works, for whom, and in what circumstances. | Masterton W et al. | — | 2021 | → |
| Prevalence of cocaine use and cocaine use disorder among adult patients with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. | Oliva F et al. | — | 2021 | → |
| Prevalence of Substance Use among Psychotic Patients and Determining Its Strongest Predictor. | Mousavi SB et al. | — | 2021 | → |
| Reducing Addiction in Bipolar Disorder via Hacking the Dopaminergic System. | Grunze H et al. | — | 2021 | → |
| Substance Misuse Trajectories and Risk of Relapse in the Early Course of Bipolar Disorder. | Lagerberg TV et al. | — | 2021 | → |
| The Heterogeneity of Longitudinal Cognitive Decline in Euthymic Bipolar I Disorder With Clinical Characteristics and Functional Outcomes. | Chen WY et al. | — | 2021 | → |
| The relationship between cannabis use and cognition in people with bipolar disorder: A systematic scoping review. | Jordan Walter T et al. | — | 2021 | → |
| Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder. | Bauer M et al. | — | 2021 | → |
| Cognitive impairment in individuals with bipolar disorder with and without comorbid alcohol and/or cocaine use disorders. | Li C et al. | — | 2020 | → |
| Comparison of the effectiveness of a 12 step substance use recovery program on quality of life. | Mokhtari MR et al. | — | 2020 | → |
| Gaps and challenges: WHO treatment recommendations for tobacco cessation and management of substance use disorders in people with severe mental illness. | Das-Munshi J et al. | — | 2020 | → |
| Heterogeneity and Polygenicity in Psychiatric Disorders: A Genome-Wide Perspective. | Wendt FR et al. | — | 2020 | → |
| Increased Risk of Dementia Among Veterans With Bipolar Disorder or Schizophrenia Receiving Care in the VA Health System. | Ahearn EP et al. | — | 2020 | → |
| Lifetime cocaine use is a potential predictor for conversion from major depressive disorder to bipolar disorder: A prospective study. | de Azevedo Cardoso T et al. | — | 2020 | → |
| Mixed States in Patients with Substance and Behavioral Addictions. | Di Nicola M et al. | — | 2020 | → |
| Prevalence and clinical correlates of substance use amongst acute psychiatric inpatients in Gauteng, South Africa. | Anic A et al. | — | 2020 | → |
| Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: Systematic review and meta-analysis. | Hunt GE et al. | — | 2020 | → |
| Psychiatric comorbidities in bipolar disorders: An examination of the prevalence and chronology of onset according to sex and bipolar subtype. | Loftus J et al. | — | 2020 | → |
| Remission and recurrence in bipolar disorder: The data from health outcomes and patient evaluations in bipolar disorder (HOPE-BD) study. | Pinto JV et al. | — | 2020 | → |
| Bipolar depression: the clinical characteristics and unmet needs of a complex disorder. | McIntyre RS et al. | — | 2019 | → |
| Brain-behavior relations and effects of aging and common comorbidities in alcohol use disorder: A review. | Sullivan EV et al. | — | 2019 | → |
| Drug-drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs. | Goodlet KJ et al. | — | 2019 | → |
| Psychiatric comorbidities in alcohol use disorder. | Castillo-Carniglia A et al. | — | 2019 | → |
| The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: A systematic review with meta-analysis and meta-regression. | Pinto JV et al. | — | 2019 | → |
| Tobacco smoking and other substance use disorders associated with recurrent suicide attempts in bipolar disorder. | Icick R et al. | — | 2019 | → |
| Trajectories of antipsychotic use before and during pregnancy and associated maternal and birth characteristics. | Schaffer AL et al. | — | 2019 | → |
| Treatment of substance use disorders with co-occurring severe mental health disorders. | Murthy P et al. | — | 2019 | → |
| Bipolar disorder, comorbid anxiety disorders, gynecomastia and dental pain: case analysis with literature review. | Kaufman KR et al. | — | 2018 | → |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. | Yatham LN et al. | — | 2018 | → |
| Estimating Prevalence of Illicit Drug Use in Yunnan, China, 2011-15. | Zhang G et al. | — | 2018 | → |
| Factors associated with false positives in MDQ screening for bipolar disorder: Insight into the construct validity of the scale. | Paterniti S et al. | — | 2018 | → |
| [Psychiatric comorbidities of Alcohol dependence]. | Dervaux A et al. | — | 2018 | → |
| Association of Alzhemier's disease with hepatitis C among patients with bipolar disorder. | Lin HC et al. | — | 2017 | → |
| History of Bipolar Disorder and the Risk of Dementia: A Systematic Review and Meta-Analysis. | Diniz BS et al. | — | 2017 | → |
| Overview of Substance Use and Mental Health Among the "Baby Boomers" Generation. | Cleary M et al. | — | 2017 | → |